SaaS startups have become the darling of Venture Capital investors, especially in the Biotechnology industry. Over the past decade, software has proverbially “eaten the world” and SaaS companies have scaled to become unicorn corporations in staggering amounts of time.
In this article, we are examining 2 VC funded SaaS startups in the Biotechnology industry.
Pluto is a B2B SaaS platform that empowers researchers to explore their data and make high-quality, meaningful discoveries in a fraction of the time. For biology labs, Pluto is the single source of truth, a secure home for organizing all of their experimental data, analysis, and figures. Researchers can upload data and run statistics- and machine learning-based analyses easily in their browser, with no coding required. Unique share links enable private sharing between collaborators, as well as public sharing of Pluto Projects to support full reproducibility of scientific manuscripts. The Pluto platform also allows researchers to compare their own results against a database of thousands of published experiments, bringing the global scientific community closer so that more life-changing discoveries can reach the world.
The Public Health Company is developing the first global biosecurity platform to provide enterprises a SaaS-enabled service for the management of bio-risks. PHC combines world-class expertise with cutting edge technology to be the global solution to enterprise risk management. PHC focuses on intersecting physical world threats across diverse use-cases to deliver actionable and predictive intelligence that enables dynamic risk management with unprecedented speed and scale. It was founded in 2020 and headquartered in Palo Alto, California.